ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0161

Cross Country Burden of Osteoarthritis in Latin America and Caribbean from 1990-2021: A Comparative and Consistent Benchmarking Analysis for the Global Burden of Disease Study 2022

malay rathod1, Eva Kalra2, Rafael Sanchez-Dopazo,3, Janmay Vala4, Saif Syed5, Akhilesh Sharma6, Ashwinikumar Shandilya7, Asmita Gera8, Mohit Lakkimsetti9, Juhi Patel10, VISHRANT AMIN11 and Hardik Desai12, 1Monmouth Medical Center, Rutgers University, Ewing, NJ, 2Trident Medical Cente, Charleston, SC, 3Larkin Community Hospital Palm Springs Campus, Hialeah, FL, 4Terna Medical College, Navi Mumbai, Maharashtra, India, 5Royal college of Surgeons,Dublin,Ireland, Dublin, Dublin, Ireland, 6Adesh Institute of Medical Sciences and Research, Bhatinda, India, 7Rural Medical college. Pravara institute of medical sciences., Ahmednagar, India, 8Tianjin medical University, Tianjin, China, Tianjin, Tianjin, China (People's Republic), 9Mamata Medical College,Khammam, Khammam, Telangana, India, 10GMERS MEDICAL COLLEGE VALSAD, 382330, Gujarat, India, 11GMERS MEDICAL COLLEGE VALSAD, Ahmedabad, India, 12Gujarat Adani Institute of Medical Sciences, Bhuj, India

Meeting: ACR Convergence 2024

Keywords: Disability, Epidemiology, Health policy, Osteoarthritis, population studies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Osteoarthritis (OA) poses a significant and escalating health challenge across Latin America and the Caribbean (LAC), driven by demographic shifts, lifestyle factors, and varying access to healthcare. This chronic condition not only diminishes quality of life due to pain and limited mobility but also strains healthcare resources and imposes substantial economic burdens. Our study spans three decades, incorporating the initial impacts of the COVID-19 pandemic, to comprehensively assess OA’s burden and inform targeted interventions in the region.

Methods: We estimated prevalence, incidence, disability adjusted life years (DALYs) due to OA by age, sex, year and location across the LAC from 1990-2021 by using global burden of disease framework. Non-fatal health outcomes were estimated using DISMOD MR 2.1, a meta regression tool.

Results: From 1990 to 2021, the prevalence of osteoarthritis (OA) exhibited significant increases across various types: OA hip rose from 718,252 (95% Uncertainty Interval: 554,170-915,546) to 2.2 million (1.7-2.9 million), OA hand from 4.7 million (3.5-6 million) to 16.4 million (12.4-20.9 million), and OA knee from 9.2 million (7.9-10.5 million) to 28.3 million (24.3-32.3 million). The age-standardized incidence rate (ASIR) showed the highest total percentage change (TPC) in Panama at 14%, while Bermuda saw the lowest increase at 4% during the same period. In terms of disability-adjusted life years (DALYs) rate (ASDALR), the highest increases were observed in Panama (16%), Mexico (16%), Belize (15%), and Nicaragua (15%) from 1990 to 2021. Regarding specific OA types, the highest ASDALR were observed in Uruguay for OA hip (30%), Argentina for OA knee (29%), and Mexico for OA hand (34%), with significant increases in Panama, Peru, and Haiti following closely. In terms of age, the highest incidence rates were observed in the 50-54 age group (624,287; 95% UI: 498,446-758,368), while the highest DALYs were found in the 60-64 age group (253,717; 95% UI: 124,051-505,055) in 2021. Females generally experienced a higher burden increase compared to males, with total prevalent count increasing by 225% versus 197%, incidence by 195% versus 176%, and DALYs by 230% versus 200% from 1990 to 2021.

Conclusion: Prevalence due to OA accounted for 8.16% of all causes of prevalence in LAC. The study highlights substantial increases in osteoarthritis prevalence and burden across various types in Latin America and the Caribbean from 1990 to 2021. These trends reveal significant disparities in age-specific incidence rates and gender differences, underscoring the pressing need for targeted healthcare interventions to alleviate the growing impact of OA on public health and healthcare systems in the region.

Supporting image 1

Global Burden and Trend of Osteoarthritis in Latin America and Caribbean from 1990_2021, All Age Counts

Supporting image 2

Sex-wise Burden of Osteoarthritis in Latin America and Caribbean Countries in 2021, Age-Standardized Rate (per 100,000 person years)


Disclosures: m. rathod: None; E. Kalra: None; R. Sanchez-Dopazo,: None; J. Vala: None; S. Syed: None; A. Sharma: None; A. Shandilya: None; A. Gera: None; M. Lakkimsetti: None; J. Patel: None; V. AMIN: None; H. Desai: None.

To cite this abstract in AMA style:

rathod m, Kalra E, Sanchez-Dopazo, R, Vala J, Syed S, Sharma A, Shandilya A, Gera A, Lakkimsetti M, Patel J, AMIN V, Desai H. Cross Country Burden of Osteoarthritis in Latin America and Caribbean from 1990-2021: A Comparative and Consistent Benchmarking Analysis for the Global Burden of Disease Study 2022 [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/cross-country-burden-of-osteoarthritis-in-latin-america-and-caribbean-from-1990-2021-a-comparative-and-consistent-benchmarking-analysis-for-the-global-burden-of-disease-study-2022/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cross-country-burden-of-osteoarthritis-in-latin-america-and-caribbean-from-1990-2021-a-comparative-and-consistent-benchmarking-analysis-for-the-global-burden-of-disease-study-2022/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology